Gosset Synmosa Biopharma General Information
Synmosa Biopharma is a leading specialty pharmaceutical company in Taiwan with a focus on R&D, manufacturing, and commercialization of drugs in cardiovascular, respiratory, urology, sex hormone/women’s health, and oncology. The company has several approved products and late-stage assets including linzagolix for uterine fibroids/endometriosis under NDA review in Taiwan. It also has commercialized silodosin for prostatic hyperplasia and other generics/specialty products. The company operates multiple GMP-certified manufacturing facilities and is active in both domestic and international markets.
Contact Information
Taiwan
Drug Pipeline
No pipeline data available
Key Partnerships
Kissei Pharmaceutical Co., Ltd. (linzagolix license), Sanofi-Aventis/Boehringer Ingelheim as agent/distributor historically, Theramex partnership via Kissei pipeline globally
Synmosa Biopharma Funding
No funding data available